نتایج جستجو برای: asunaprevir

تعداد نتایج: 282  

Journal: :Environmental pollution 2007
Loretto Contreras Matías H Medina Santiago Andrade Valeria Oppliger Juan A Correa

Copper effects on the early developmental gametophytic and sporophytic stages of the kelp Lessonia nigrescens were tested in gradients of increasing concentrations of ASV-labile copper. The results demonstrated a high sensitivity to copper of all life-history stages of the alga, where even the lowest tested concentration affected spore release as well as their subsequent settlement. More signif...

2017
Hyun Woong Lee Ki Young Yoo Joung Won Won Hyung Joon Kim

Background/Aims Chronic hepatitis C (CHC) is a major comorbidity in patients with hemophilia. Methods Patients (n=30) were enrolled between September 2015 and April 2016. Twenty-six patients were genotype 1 (1b, n=21; 1a, n=5) and four patients were genotype 2a/2b. Among 21 patients with genotype 1b, Y93H resistance-associated variants (RAVs) were detected in three patients (14.3%). We evalua...

2016
Tatsuya Ide Yuichiro Eguchi Masaru Harada Kunihide Ishii Masaru Morita Yasuyo Morita Gen Sugiyama Hirofumi Fukushima Yoichi Yano Kazunori Noguchi Hiroki Nakamura Junjiro Hisatomi Hiroto Kumemura Miki Shirachi Shinji Iwane Michiaki Okada Yuichi Honma Teruko Arinaga-Hino Ichiro Miyajima Kei Ogata Reiichiro Kuwahara Keisuke Amano Toshihiro Kawaguchi Ryoko Kuromatsu Takuji Torimura

BACKGROUND The aim of this study was to evaluate the efficacy of daclatasvir plus asunaprevir therapy in patients infected with hepatitis C virus and determine its relevance to resistant variants. METHODS A total of 629 consecutive patients infected with hepatitis C virus genotype 1 were assessed. Daclatasvir (60 mg/day) plus asunaprevir (200 mg/day) was given for 24 weeks. The virological re...

2014
Hiromitsu Kumada Yoshiyuki Suzuki Kenji Ikeda Joji Toyota Yoshiyasu Karino Kazuaki Chayama Yoshiiku Kawakami Akio Ido Kazuhide Yamamoto Koichi Takaguchi Namiki Izumi Kazuhiko Koike Tetsuo Takehara Norifumi Kawada Michio Sata Hidetaka Miyagoshi Timothy Eley Fiona McPhee Andrew Damokosh Hiroki Ishikawa Eric Hughes

UNLABELLED All-oral combinations of direct-acting antivirals may improve efficacy and safety outcomes for patients with hepatitis C virus (HCV) infection, particularly those who are poor candidates for current interferon/ribavirin-based regimens. In this open-label, phase 3 study, 135 interferon-ineligible/intolerant and 87 nonresponder patients with chronic HCV genotype 1b infection were enrol...

Journal: :The Kobe journal of medical sciences 2016
Keisuke Arai Kaori Kuramitsu Takumi Fukumoto Masahiro Kido Atsushi Takebe Motofumi Tanaka Hisoka Kinoshita Tetsuo Ajiki Hirochika Toyama Sadaki Asari Tadahiro Goto Yonson Ku

There are few descriptions of severe thrombocytopenia during the early postoperative period after liver transplantation, and these have not been fully documented in the literature. Here, we report a case of drug-induced thrombocytopenia requiring transfusion of blood products after living donor liver transplantation. We determined that this was not caused by the interferon-free anti-viral thera...

2017
Ayumi Sugiura Shuichi Wada Hiromitsu Mori Takefumi Kimura Yoshiaki Matsuda Naoki Tanaka Eiji Tanaka Kendo Kiyosawa

Persistent hepatitis C virus (HCV) infection may induce autoimmune diseases and chronic hepatitis C is sometimes accompanied by autoimmune hepatitis (AIH). However, we are worried about the treatment for chronic hepatitis C-AIH overlap syndrome because interferon-based antiviral therapies may enhance autoimmunity and immunosuppressive corticosteroid administration may promote viral replication....

Journal: :Journal of hepatology 2013
Yoshiyuki Suzuki Kenji Ikeda Fumitaka Suzuki Joji Toyota Yoshiyasu Karino Kazuaki Chayama Yoshiiku Kawakami Hiroki Ishikawa Hideaki Watanabe Wenhua Hu Timothy Eley Fiona McPhee Eric Hughes Hiromitsu Kumada

BACKGROUND & AIMS Improved therapeutic options for chronic hepatitis C virus (HCV) infection are needed for patients who are poor candidates for treatment with current regimens due to anticipated intolerability or low likelihood of response. METHODS In this open-label, phase 2a study of Japanese patients with chronic HCV genotype 1b infection, 21 null responders (<2 log₁₀ HCV RNA reduction af...

Journal: :hepatitis monthly 0
seyed moayed alavian baqiyatallah research center for gastroenterology and liver diseases (brcgl), baqiyatallah university of medical sciences, tehran, ir iran; middle east liver diseases (meld) center, tehran, ir iran; meta-analysis study group for treatment of hepatitis c, iran hepatitis network, tehran, ir iran; baqiyatallah research center for gastroenterology and liver diseases (brcgl), baqiyatallah university of medical sciences, tehran, ir iran. tel: +98-2188945186, fax: +98-2188945188 mohammad saeid rezaee-zavareh middle east liver diseases (meld) center, tehran, ir iran; meta-analysis study group for treatment of hepatitis c, iran hepatitis network, tehran, ir iran; students’ research committee, baqiyatallah university of medical sciences, tehran, ir iran

conclusions among the treatment regimens containing dcv, dcv/sof has the highest svr rate for the treatment of infection with different hcv genotypes in different patient contexts; thus, this regimen shows promise for the treatment of hcv infections. results we found six different regimens containing dcv: dcv/asunaprevir (asv), dcv/asv/beclubavir, dcv/pegylated interferon lambda or alpha/rbv wi...

Journal: :JAMA 2015
Fred Poordad William Sievert Lindsay Mollison Michael Bennett Edmund Tse Norbert Bräu James Levin Thomas Sepe Samuel S Lee Peter Angus Brian Conway Stanislas Pol Nathalie Boyer Jean-Pierre Bronowicki Ira Jacobson Andrew J Muir K Rajender Reddy Edward Tam Grisell Ortiz-Lasanta Victor de Lédinghen Mark Sulkowski Navdeep Boparai Fiona McPhee Eric Hughes E Scott Swenson Philip D Yin

IMPORTANCE The antiviral activity of all-oral, ribavirin-free, direct-acting antiviral regimens requires evaluation in patients with chronic hepatitis C virus (HCV) infection. OBJECTIVE To determine the rates of sustained virologic response (SVR) in patients receiving the 3-drug combination of daclatasvir (a pan-genotypic NS5A inhibitor), asunaprevir (an NS3 protease inhibitor), and beclabuvi...

2012
Fenglian Xu Elizabeth A Sullivan Richard C Madden Deborah Black Lisa R Jackson Pulver

BACKGROUND The Indigenous population of Australia was estimated as 2.5% and under-reported. The aim of this study is to improve statistical ascertainment of Aboriginal women giving birth in New South Wales. METHODS This study was based on linked birth data from the Midwives Data Collection (MDC) and the Registry of Births Deaths and Marriages (RBDM) of New South Wales (NSW). Data linkage was ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید